Condition
Failed Moderate Sedation During Procedure
Total Trials
6
Recruiting
0
Active
0
Completed
5
Success Rate
83.3%-3% vs avg
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
83.3%
-3.2% vs benchmark
Late-Stage Pipeline
83%
5 trials in Phase 3/4
Results Transparency
0%
0 of 5 completed with results
Key Signals
83% success
Data Visualizations
Phase Distribution
6Total
Early P 1 (1)
P 4 (5)
Trial Status
Completed5
Terminated1
Trial Success Rate
83.3%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT03067974Early Phase 1TerminatedPrimary
Intranasal Ketamine for Pediatric Procedural Sedation: a Feasibility Study
NCT02878837Phase 4CompletedPrimary
Dexmedetomidine vs Midazolam for Intraoperative Sedation
NCT02732132Phase 4CompletedPrimary
A Comparison of the Sedation During Endoscopy in Children
NCT02239445Phase 4Completed
Intranasal Dexmedetomidine VS Oral Chloral Hydrate for Rescue Sedation During Magnetic Resonance Imaging
NCT02127489Phase 4CompletedPrimary
The Effects of Single-dose Rectal Midazolam Application on Post-operative Recovery
NCT01748630Phase 4CompletedPrimary
Effects of Dexmedetomidine on the Postoperative Experience in Children
Showing all 6 trials